Ronit Yarden Ph.D. Mhsa
About Ronit Yarden Ph.D. Mhsa
Ronit Yarden, Ph.D., Mhsa, serves as the Program Director of the Epidemiology Branch at the National Institutes of Health. With extensive experience in academia and medical affairs, she has held various positions in organizations such as Georgetown University and the Colorectal Cancer Alliance.
Work at National Institutes of Health
Ronit Yarden, Ph.D., currently serves as the Program Director of the Epidemiology Branch at the National Institutes of Health (NIH). She began this role in 2022 and has been involved in overseeing various epidemiological research initiatives. Prior to this position, she worked as a Health Science Administrator in the Precision Medicine sector of the NIH from 2020 to 2022. Her experience at NIH contributes to her extensive background in genomics and public health.
Education and Expertise
Ronit Yarden holds multiple degrees from prestigious institutions. She earned a Ph.D. in Biochemistry and Molecular Biology from Georgetown University. Additionally, she completed a Master in Health System Administration at Georgetown University and a Master of Science in Cancer Immunology from Tel Aviv University. Her academic background provides a strong foundation for her work in epidemiology and public health.
Background
Before her current role at the NIH, Ronit Yarden held various positions in the field of health and research. She served as the Senior Director of Medical Affairs at the Colorectal Cancer Alliance from 2018 to 2020. Additionally, she worked as a review editor for cancer endocrinology at Frontiers from 2014 to 2020. Her career also includes significant roles at Sheba Tel HaShomer City of Health in Israel and at Georgetown University.
Achievements
Throughout her career, Ronit Yarden has made contributions to the fields of genomics and epidemiology. She has held leadership roles in various organizations, including serving as the Head of the Lab of Genomics Applications at Sheba Tel HaShomer from 2002 to 2011. Her involvement in research and administration at the NIH and other institutions reflects her commitment to advancing health science and precision medicine.